Fixed-Dose Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: Results of a Randomized, Placebo-Controlled Study and Open-Label Extension

Background: Subcutaneous methylnaltrexone (MNTX), dosed based on body weight, is efficacious and well tolerated in inducing bowel movements in patients with advanced illness and opioid-induced constipation (OIC); however, fixed-dose administration of MNTX may improve ease of administration. Objectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Bull, Janet, Wellman, Charles V., Israel, Robert J., Barrett, Andrew C., Paterson, Craig, Forbes, William P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492709/
https://www.ncbi.nlm.nih.gov/pubmed/25973526
http://dx.doi.org/10.1089/jpm.2014.0362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492709/
https://www.ncbi.nlm.nih.gov/pubmed/25973526
http://dx.doi.org/10.1089/jpm.2014.0362

Ejemplares similares